Pall Ultroser G serum substitute 血清替代品 产品介绍：
Ultroser™ G血清替代品可以在细胞培养基中成功替代FCS（胎牛血清）。Ultroser™ G血清替代品设计用于依赖贴壁细胞的体外培养。已在羊膜液细胞原代培养中测试过，旨在确认其核型分析能力。Ultroser G血清替代品通过CE标记注册。
Ultroser G血清替代品通过一系列质量测试，包括PH、蛋白质浓度、无菌控制、细菌和真菌、牛病毒（BHV1-DVB/MM,红细胞吸附）、支原体、Hep G2细胞增殖能力、核型分析等。

Pall Ultroser G serum substitute 血清替代品 产品特性：
半固定成份确保批次间可重现性
低蛋白含量
方便使用和保藏
 Ultroser G血清替代品浓度是胎牛血清浓度的5倍（2%血清替代品相当于10%胎牛血清）

Pall Ultroser G serum substitute 血清替代品 英文简述：
Ultroser™ G serum substitute can successfully replace FCS （fetal calf serum） in cell culture medium. It is designed for the in vitro culture of anchorage-dependent cells. It is specially tested as the primary culture from amniotic liquid cells and is designed to confirm their ability for karyotyping. Ultroser G serum substitute is CE mark-certified.
Ultroser G serum substitute has a concentration five times higher than fetal calf serum （2 % of reconstituted Ultroser G serum substitute is equivalent to 10%  fetal calf serum in the basal medium）.

Quality Control Tests
Tests usually performed on Ultroser G serum substitute are:
● Physicochemical parameters pH
● Protein concentration
● Sterility control
● Bacteria & Fungi
● Bovine viruses （BHV1-DVB/MM, hemadsorbents）
● Proliferation capacity on Hep G2
● Mycoplasma
● Karyotyping

Cells successfully tested with Ultroser™ G serum substitute 已经验证过的细胞类型如下:

Human myocytes，Glial cells，Chicken fibroblasts，P3HR1， Rat myocytes，Amniotic cells，    Thyroid cells，Hypothalamic cells，HeLa，Vero，Chondrocytes，Astrocytes，CHO，Leydig cells，MRC-5，BHK，Bone marrow cells， Arterial cells，Lewis cells，    Fibroblasts skin cells，Raji， Keratinocytes，Erythoblastes，Promyelocytes HL60等细胞种类，其他细胞类型可以参考文献，或者初期通过细胞培养实验测试获得。